20 YEARS OF 131IODINE-METAIODOBENZYLGUANIDINE (131I-MIBG) THERAPY UPFRONT: A RETROSPECTIVE ANALYSIS OF ACUTE TOXICITY

被引：0
|
作者：
Bleeker, Gitta [1 ]
Schoot, Reineke [1 ]
Caron, Huib [1 ]
van Eck, Berthe
de Kraker, Jan [1 ]
Tytgat, Godelieve [1 ]
机构：
[1] Emma Childrens Hosp AMC, Amsterdam, Netherlands
来源：
PEDIATRIC BLOOD & CANCER | 2009年 / 53卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：736 / 736
页数：1
相关论文
共 50 条
  • [21] The treatment of malignant metaiodobenzylguanidine (131I-MIBG):: A comprehensive review of 116 reported patients
    Loh, KC
    Fitzgerald, PA
    Matthay, KK
    Yeo, PPB
    Price, DC
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (11) : 648 - 658
  • [22] High-specific-activity 131iodine-metaiodobenzylguanidine for therapy of unresectable pheochromocytoma and paraganglioma
    Dillon, Joseph S.
    Bushnell, David
    Laux, Douglas E.
    FUTURE ONCOLOGY, 2021, 17 (10) : 1131 - 1141
  • [23] Phase I Study of Vorinostat as a Radiation Sensitizer with 131I-Metaiodobenzylguanidine (131I-MIBG) for Patients with Relapsed or Refractory Neuroblastoma
    DuBois, Steven G.
    Groshen, Susan
    Park, Julie R.
    Haas-Kogan, Daphne A.
    Yang, Xiaodong
    Geier, Ethan
    Chen, Eugene
    Giacomini, Kathy
    Weiss, Brian
    Cohn, Susan L.
    Granger, M. Meaghan
    Yanik, Gregory A.
    Hawkins, Randall
    Courtier, Jesse
    Jackson, Hollie
    Goodarzian, Fariba
    Shimada, Hiroyuki
    Czarnecki, Scarlett
    Tsao-Wei, Denice
    Villablanca, Judith G.
    Marachelian, Araz
    Matthay, Katherine K.
    CLINICAL CANCER RESEARCH, 2015, 21 (12) : 2715 - 2721
  • [24] Sequelae and survivorship in patients treated with 131I-MIBG therapy
    Sze, W. C. C.
    Grossman, A. B.
    Goddard, I.
    Amendra, D.
    Shieh, S. C. C.
    Plowman, P. N.
    Drake, W. M.
    Akker, S. A.
    Druce, M. R.
    BRITISH JOURNAL OF CANCER, 2013, 109 (03) : 565 - 572
  • [25] IMPACT OF RESPONSE TO PRIOR THERAPY ON OUTCOME FOR REFRACTORY VS. RELAPSED NEUROBLASTOMA PATIENTS TREATED WITH 131I-METAIODOBENZYLGUANIDINE (131I-MIBG)
    Matthay, K. K.
    Zhou, M.
    Doral, M.
    Villablanca, J.
    Yanik, G.
    DuBois, S.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S150 - S151
  • [26] Treatment of neuroendocrine tumours in adults with 131I-MIBG therapy
    Bomanji, JB
    Wong, W
    Gaze, MN
    Cassoni, A
    Waddington, W
    Solano, J
    Ell, PJ
    CLINICAL ONCOLOGY, 2003, 15 (04) : 193 - 198
  • [27] Upfront Treatment of High-Risk Neuroblastoma With a Combination of 131I-MIBG and Topotecan
    Kraal, Kathelijne C. J. M.
    Tytgat, Godelieve A. M.
    van Eck-Smit, Berthe L. F.
    Kam, Boen
    Caron, Huib N.
    van Noesel, Max
    PEDIATRIC BLOOD & CANCER, 2015, 62 (11) : 1886 - 1891
  • [28] Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy 123I-MIBG Versus Posttherapy 131I-MIBG Imaging
    Pandit-Taskar, Neeta
    Zanzonico, Pat
    Hilden, Patrick
    Ostrovnaya, Irina
    Carrasquillo, Jorge A.
    Modak, Shakeel
    CLINICAL NUCLEAR MEDICINE, 2017, 42 (10) : 741 - 748
  • [29] Individualised 131I-mIBG Therapy in the Management of Refractory and Relapsed Neuroblastoma
    George, S. L.
    Kirk, S. J.
    Lancaster, D.
    Vaidya, S. J.
    Mandeville, H.
    Saran, F.
    Chittenden, S. J.
    Pearson, A. D. J.
    Du, Y.
    Flux, G. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S244 - S244
  • [30] 131I-MIBG therapy: Dosimetry estimations in neuroendocrine patients.
    Castellani, M. R.
    Chiesa, C.
    Luksch, R.
    Aliberti, A.
    Maccauro, M.
    Seregni, E.
    Bombardieri, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S317 - S317
12345